Urticaria aggravated and Nosebleed

Summary:

Nosebleed is found among people with Urticaria aggravated, especially for people who are female, 30-39 old.

The study analyzes which people have Nosebleed with Urticaria aggravated. It is created by eHealthMe based on reports of 46 people who have Urticaria aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Urticaria aggravated?

Urticaria aggravated (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,057 drugs and 723 conditions by eHealthMe. Check the latest studies of Urticaria aggravated.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,074 drugs and 3,094 conditions by eHealthMe. Check the latest studies of Nosebleed.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

46 people who have Urticaria Aggravated and Nosebleed are studied.

Would you have Nosebleed when you have Urticaria aggravated?

Gender of people who have Urticaria Aggravated and experienced Nosebleed *:

  • female: 71.43 %
  • male: 28.57 %

Age of people who have Urticaria Aggravated and experienced Nosebleed *:

  • 0-1: 2.86 %
  • 2-9: 8.57 %
  • 10-19: 8.57 %
  • 20-29: 2.86 %
  • 30-39: 31.43 %
  • 40-49: 8.57 %
  • 50-59: 22.86 %
  • 60+: 14.29 %

Common co-existing conditions for these people *:

  1. Asthma: 4 people, 8.70%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 6.52%
  3. Nausea (feeling of having an urge to vomit): 3 people, 6.52%
  4. Constipation: 3 people, 6.52%
  5. Itching: 3 people, 6.52%
  6. Hypersensitivity: 3 people, 6.52%
  7. Growth Hormone Deficiency: 2 people, 4.35%
  8. Joint Pain: 2 people, 4.35%
  9. Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 2 people, 4.35%
  10. Hypotonia (low muscle tone): 2 people, 4.35%

Common drugs taken by these people *:

  1. Xolair: 17 people, 36.96%
  2. Benadryl: 16 people, 34.78%
  3. Zantac: 11 people, 23.91%
  4. Amoxicillin: 8 people, 17.39%
  5. Pantoprazole Sodium: 7 people, 15.22%
  6. Concerta: 4 people, 8.70%
  7. Singulair: 3 people, 6.52%
  8. Ibrance: 3 people, 6.52%
  9. Atarax: 3 people, 6.52%
  10. Zyrtec: 3 people, 6.52%

Common symptoms for these people *:

  1. Itching: 17 people, 36.96%
  2. Urinary Tract Infection: 16 people, 34.78%
  3. Rashes (redness): 15 people, 32.61%
  4. Pain: 15 people, 32.61%
  5. Cough: 15 people, 32.61%
  6. Malaise (a feeling of general discomfort or uneasiness): 15 people, 32.61%
  7. Body Temperature Decreased: 14 people, 30.43%
  8. Feeling Abnormal: 14 people, 30.43%
  9. Fever: 13 people, 28.26%
  10. Dizziness: 12 people, 26.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Nosebleed:

All the conditions that are associated with Nosebleed:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Nosebleed and Urticaria aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: